-
- USUKI Kensuke
- Department of Hematology, Medical Center Tokyo
Bibliographic Information
- Other Title
-
- 再生不良性貧血の診断と治療
- サイセイ フリョウセイ ヒンケツ ノ シンダン ト チリョウ
Search this article
Abstract
<p>Treatments of aplastic anemia comprise supportive therapy and aplastic anemia-specific therapy to recover from hematopoiesis. Supportive therapy includes transfusion, granulocyte colony-stimulating factor, and iron chelation therapy in addition to symptomatic treatment. Aplastic anemia-specific treatments that aim to achieve hematopoietic recovery are immunosuppressive therapy, thrombopoietin receptor agonist (TPO-RA) treatment, allogeneic hematopoietic stem cell transplantation, and anabolic hormone therapy. Although the transplantation achieves complete recovery of hematopoiesis (healing), there is a risk of death from transplant-related complications. The most effective drug therapy is the combination of TPO-RA and the immunotherapy combined with anti-thymocyte globulin and cyclosporine. This treatment is also effective against secondary, drug-induced, or hepatitis-associated aplastic anemia. In the treatment of aplastic anemia, the treatment choice is made based on the disease severity and patient ages.</p>
Journal
-
- Rinsho Ketsueki
-
Rinsho Ketsueki 62 (8), 922-930, 2021
The Japanese Society of Hematology
- Tweet
Details 詳細情報について
-
- CRID
- 1390007834745542016
-
- NII Article ID
- 130008086007
-
- NII Book ID
- AN00252940
-
- ISSN
- 18820824
- 04851439
-
- NDL BIB ID
- 031712834
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- CiNii Articles
-
- Abstract License Flag
- Disallowed